Published on
March 21, 2019
- 10:00 GMT
Academic institutions grant license for CRISPR-based SHERLOCK in developed world, protect rights for use in developing world
A group of academic institutions has granted a license for SHERLOCK™, the highly-sensitive, low-cost CRISPR-based diagnostic, for commercial uses in the developed world, while reserving rights to enable its broad use by organizations to serve developing …
Distribution channels:
Healthcare & Pharmaceuticals Industry
